Korea Launches Inter-agency Body To Stimulate Local R&D, Earmarks $440 Million For Program
This article was originally published in PharmAsia News
Executive Summary
SEOUL - The Korean government has set up an inter-ministry team to support local pharmaceutical companies develop globally competitive drugs. The team will offer R&D training for companies looking to diversify their generic pipelines with innovative products as well as some of the start-up cash needed for new R&D programs